Non-viral infections and antimicrobial resistance in the time of COVID-19: what to expect?

Boyanova, Lyudmila; Markovska, Rumyana; Mitov, Ivan; Gergova, Raina

Boyanova, Lyudmila; Markovska, Rumyana; Mitov, Ivan; Gergova, Raina.

Afiliação

Boyanova L; Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.
Markovska R; Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.
Mitov I; Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.
Gergova R; Department of Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.

Expert Rev Clin Pharmacol ; 15(8): 907-909, 2022 08.

Article em En | MEDLINE | ID: mdl-35912839

Assuntos

COVID-19; Antibacterianos/farmacologia; Antibacterianos/uso terapêutico; Farmacorresistência Bacteriana; Humanos; SARS-CoV-2

Palavras-chave

Antibiotics; COVID-19; antifungals; bacterial infections; coinfections; fungal infections; resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article